The Fair Work Commission has upheld the firing of a Melbourne University professor who was found to have pursued an inappropriate personal relationship with a former employee who later complained she had been “groomed”.
A sex discrimination case by the only female partner at global tech research company Information Services Group has been discontinued after a judge panned the “ludicrous” number of witnesses expected to give evidence.
Car electronics company Directed Electronics has challenged a ruling that partially dismissed its case over the alleged misappropriation of trade secrets by a former manager, who was found to have pocketed $3.6 million in commissions through a secret agreement with rival Hanhwa.
Construction firm CIMIC has won its bid to view identifying information about institutional investors in a shareholder class action, despite the applicant’s claims it could deter group members from signing on to the case.
The High Court has rejected dam services provider Sunwater’s request that it weigh in on a dispute over insurance coverage for a $440 million class action settlement with victims of the 2010-2011 floods in Queensland.
The farmers leading a class action against Advanta Seeds over contaminated product have brought their case to the High Court, challenging an appeals court’s holding that a disclaimer nullified the company’s duty to protect growers against economic loss.
A judge has granted a discovery bid by two of Gina Rinehart’s children as a long-running fight over ownership of a valuable mining tenement nears trial, and has rejected her company’s argument that they were solely responsible for dragging out a dispute over documents.
Award-wining architecture firm Ashton Raggatt McDougall and its former boss have agreed to pay a combined $975,000 in penalties for attempting to rig bids on a $250 million building project at Charles Darwin University.
Carnival has won its bid to strike out a class action over norovirus outbreaks on its Sun Princess cruise ship.
Bayer told a jury that clinical trials from the 1990’s to 2014 showed its Essure birth control device was “safe and efficacious”, as the pharmaceutical giant faces trial in a class action by patients who claim they suffered debilitating injuries from the device.